Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPharm Incorporated, Maroerre, GA 30062. Mfg By: Swiss Caps AG, Kirchberg, Switzerland. NDC: 61748-025-01
Published September 12, 2018 · Recall initiated: August 24, 2018
Summary
FDA records drug Class II recall D-1183-2018, published September 12, 2018 and initiated August 24, 2018. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 23,788 100-count bottles; Lot: Lots: 1165280100, 1165280101, EXP 3/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Akorn, Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lots: 1165280100, 1165280101, EXP 3/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevofloxacin Ophthalmic Solution, 0.5%, 5 mL bottles, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, ILJune 7, 2023
- FDAClobetasol Propionate Cream, USP, 0.05%, packaged in a) 15g tubes, b) 30g tubes, and c) 60g tubes, Rx Only,June 7, 2023
- FDALevofloxacin Injection 500mg/20 mL (25 mg/mL), For Intravenous Infusion, packaged in a) 20mL vials and b) 30June 7, 2023
- FDATropicamide Ophthalmic Solution, USP 0.1%, 15 mL bottles, Rx only, Distributed by: Akorn Operating CompanyJune 7, 2023
- FDAAvKARE Valsartan and Hydrochlorothiazide 320 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactured for:September 12, 2018
- FDAVirt-Nate Tablets, Number of units per package: 100 Tablets Package Type: 100 Tablets/BottleSeptember 12, 2018
Questions about this recall
Was Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPharm Incorporated, Maroerre, GA 30062. Mfg By: Swiss Caps AG, Kirchberg, Switzerland. NDC: 61748-025-01 recalled?
Yes. FDA published recall D-1183-2018 on September 12, 2018. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.
What should I do if I have this product?
Voluntary: Firm initiated · Letter